AGRDX
Price
$63.52
Change
+$0.45 (+0.71%)
Updated
Aug 21 closing price
Net Assets
14.72B
RGAEX
Price
$86.79
Change
+$0.78 (+0.91%)
Updated
Aug 21 closing price
Net Assets
342.42B
Interact to see
Advertisement

AGRDX vs RGAEX

AGRDX vs RGAEX Comparison Chart in %
View a ticker or compare two or three
VS
AGRDX vs. RGAEX commentary
Aug 23, 2026

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AGRDX is a StrongBuy and RGAEX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
RGAEX has more cash in the bank: 342B vs. AGRDX (14.7B). RGAEX pays higher dividends than AGRDX: RGAEX (0.22) vs AGRDX (0.00). AGRDX was incepted earlier than RGAEX: AGRDX (13 years) vs RGAEX (24 years). RGAEX (0.63) and AGRDX (0.61) have similar cost to investors . AGRDX is a more actively managed with annual turnover of: 38.00 vs. RGAEX (32.00). AGRDX has a lower initial minimum investment than RGAEX: AGRDX (0) vs RGAEX (250). RGAEX annual gain was more profitable for investors over the last year : 5.47 vs. AGRDX (-1.57). RGAEX return over 5 years is better than : 16.97 vs. AGRDX (12.65).
AGRDXRGAEXAGRDX / RGAEX
Total Expense Ratio0.480.6376%
Annual Report Gross Expense Ratio0.610.6397%
Fund Existence13 years24 years-
Gain YTD5.7439.40461%
Front LoadN/AN/A-
Min. Initial Investment0250-
Min. Initial Investment IRAN/AN/A-
Net Assets14.7B342B4%
Annual Yield % from dividends0.000.22-
Returns for 1 year-1.575.47-29%
Returns for 3 years36.0246.9877%
Returns for 5 years12.6516.9775%
Returns for 10 years117.87100.96117%
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
RNWEX108.151.60
+1.50%
American Funds New World R-4
CMJIX53.180.37
+0.70%
Calvert US Mid Cap Core Rspnb Idx I
PSSJX27.190.18
+0.67%
Principal SmallCap S&P 600 Index J
SVFCX99.570.66
+0.67%
Smead Value C
CRRVX10.78-0.01
-0.09%
Columbia Real Estate Equity Inst2